Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo?

Journal of Experimental Medicine

Volumn 183, Issue 3, 1996, Pages 769-776

  Huang, Alex Y C ^a   Bruce, Allen T ^a   Pardoll, Drew M ^a   Levitsky, Hyani I ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; GENETIC TRANSFECTION; HAPLOTYPE; IMMUNIZATION; IMMUNOCOMPETENCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD80; BONE MARROW; CAPSID; CELL LINE; CLONE CELLS; COLONIC NEOPLASMS; CROSSES, GENETIC; EPITOPES; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; ORTHOMYXOVIRIDAE; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; VIRAL CORE PROTEINS;

EID: 0029864363     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.3.769     Document Type: Article

References (23)

1. Janeway, C.J., and K. Bottomly. 1994. Signals and signs for lymphocyte responses. Cell. 71:1065-1068.
2. Jenkins, M.K., and J.G. Johnson. 1993. Molecules involved in T-cell costimulation. Curr. Opin. Immunol. 3:361-367.
3. Mueller, D.L., M.K. Jenkins, and R.H. Schwartz. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7:445-480.
4. + cytotoxic T lymphocytes in the absence of exogenous help. J. Exp. Med. 177:1791-1796.
5. Norton, S.D., D.E. Hovinen, and M.K. Jenkins. 1991. IL-2 secretion and T cell clonal anergy are induced by distinct biochemical pathways. J. Immunol. 146:1125-1129.
6. Schwartz, R.H. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interteukin-2 production and immunotherapy. Cell. 71:1065-1068.
7. Tan, P., C. Anasetti, J.A. Hansen, J. Melrose, M. Brunvand, J. Bradshaw, J.A. Ledbetter, and P.S. Linsley. 1993. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J. Exp. Med. 177:165-173.
8. Shahinian, A., K. Pfeffer, K.P. Lee, T.M. Kundig, K. Kishihara, A. Wakeham, K. Kawai, P.S. Ohashi, C.B. Thompson, and T.W. Mak. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science (Wash. DC). 261:609-612.
9. Azuma, M., M. Cayabyab, J.H. Phillips, and L.L. Lanier. 1993. Requirements for CD28-dependent T cell-mediated cytotoxicity. J. Immunol. 150:2091-2101.
10. Chen, L., S. Ashe, W.A. Brady, I. Hellstrom, K.E. Hellstrom, J.A. Ledbetter, P. McGowan, and P.S. Linsley. 1992. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4 Cell. 71:1093-1102.
11. + T cells by B7-transfected melanoma cells. Science (Wash. DC). 259:368-370.
12. Yang, G., K.E. Hellstrom, I. Hellstrom, and L. Chen. 1995. Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules. J. Immunol. 154:2794-2800.
13. Chen, L., P. McGowan, S. Ashe, J. Johnston, Y. Li, I. Hellstrom, and K.E. Hellstrom. 1994. Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J. Exp. Med. 179:523-532.
14. Huang, A.Y., P. Golumbek, M. Ahmadzadeh, E. Jaffee, D. Pardoll, and H. Levitsky. 1994. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science (Wash. DC). 264:961-965.
15. Bevan, M.J. 1976. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. J. Immunol. 117:2233-2238.
16. Bevan, M.J. 1976. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143: 1283-1288.
17. Fetten, J.V., N. Roy, and E. Gilboa. 1991. A frameshift mutation at the NH2 terminus of the nucleoprotein gene does not affect generation of cytotoxic T lymphocyte epitopes. J. Immunol. 147:2697-2705.
18. Townsend, S.E., F.W. Su, J.M. Atherton, and J.P. Allison. 1994. Specificity and longevity of antitumor immune responses induced by B7-transfected tumors. Cancer Res. 54: 6477-6483.
19. + tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice. J. Exp. Med. 181: 619-629.
20. Azuma, M., M. Cayabyab, D. Buck, J.H. Phillips, and L.L. Lanier. 1992. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. J. Immunol. 149:1115-1123.
21. Nandi, D., J.A. Gross, and J.P. Allison. 1994. CD28-mediated costimulation is necessary for optimal proliferation of murine NK cells. J. Immunol. 152:3361-3369.
22. Wu. T.-C., A.Y.C. Huang, E.M. Jaffee, and D.M. Pardoll. 1995. A reassessment of the role of B7-1 expression in tumor rejection. J. Exp. Med. 182:1-7.
23. Kundig, T.M., M.F. Bachmann, C. Dipaolo, J.J.L. Simard, M. Battegay, H. Lother, A. Gessner, K. Kuhlcke, P.S. Ohashi, H. Hengartner, and R.M. Zindernagel. 1995. Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science (Wash. DC). 268:1343-1347.